BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3365912)

  • 1. Hepatic safety of two analgesics used over the counter: ibuprofen and aspirin.
    Freeland GR; Northington RS; Hedrich DA; Walker BR
    Clin Pharmacol Ther; 1988 May; 43(5):473-9. PubMed ID: 3365912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal safety of two analgesics used over the counter: ibuprofen and aspirin.
    Bonney SL; Northington RS; Hedrich DA; Walker BR
    Clin Pharmacol Ther; 1986 Oct; 40(4):373-7. PubMed ID: 3530585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals].
    Amanuma F; Okuyama S; Orikasa S; Hashimoto S; Yamada C; Sakagawa T; Tsutsui Y; Tarumoto Y; Aihara H; Kameyama T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):345-54. PubMed ID: 6611288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa.
    Lanza FL; Hubsher JA; Walker BR
    J Clin Pharmacol; 1981 Apr; 21(4):157-61. PubMed ID: 7240437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaprozin-induced fulminant hepatitis.
    Purdum PP; Shelden SL; Boyd JW; Shiffman ML
    Ann Pharmacother; 1994 Oct; 28(10):1159-61. PubMed ID: 7841569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre double-blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis.
    Hubsher JA; Ballard IM; Walker BR; Gold JA
    J Int Med Res; 1979; 7(1):69-76. PubMed ID: 369925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control.
    Lussier A; LeBel E; Tétreault L
    J Clin Pharmacol; 1982 Apr; 22(4):173-8. PubMed ID: 6980231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
    Fries JF; Bruce B
    J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare adverse reactions to nonsteroidal antiinflammatory drugs (3).
    O'Brien WM; Bagby GF
    J Rheumatol; 1985 Jun; 12(3):562-7. PubMed ID: 3900394
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaprozin-induced symptomatic hepatotoxicity.
    Kethu SR; Rukkannagari S; Lansford CL
    Ann Pharmacother; 1999 Sep; 33(9):942-4. PubMed ID: 10492496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Brogden RN
    Drugs; 1986 Oct; 32(4):291-312. PubMed ID: 3536423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen or aspirin in rheumatoid arthritis therapy.
    Blechman WJ; Schmid FR; April PA; Wilson CH; Brooks CD
    JAMA; 1975 Jul; 233(4):336-40. PubMed ID: 1095794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ibuprofen (Motrin). A new antirheumatic agent.
    Lewis JR
    JAMA; 1975 Jul; 233(4):364-5. PubMed ID: 1173655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric irritation of oxaprozin, a new nonsteroidal, antiinflammatory drug, in comparison to acetylsalicylic acid and indomethacin: a gastric potential difference analysis.
    Lücker PW; Venitz J; Ahrens S; Kaiser PM
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):469-75. PubMed ID: 3683021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series.
    Riley TR; Smith JP
    Am J Gastroenterol; 1998 Sep; 93(9):1563-5. PubMed ID: 9732947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorenal Safety of OTC Analgesics.
    White WB; Kloner RA; Angiolillo DJ; Davidson MH
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):103-118. PubMed ID: 29421936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oxaprozin alone or in combination with aspirin on hemostasis and plasma protein binding.
    Kahn SB; Hubsher JA
    J Clin Pharmacol; 1983 Apr; 23(4):139-46. PubMed ID: 6863578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory drugs and gastrointestinal bleeding: a comparison of aspirin and ibuprofen.
    Schmid FR; Culic DD
    J Clin Pharmacol; 1976; 16(8-9):418-25. PubMed ID: 787015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of oxaprozin.
    Davies NM
    Clin Pharmacokinet; 1998 Dec; 35(6):425-36. PubMed ID: 9884815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.